• Gamifying Vision: How Mobile Gaming Is Tracking Vision Degradation in Patients

    Jun 15 | Bio-IT World | Tilak Healthcare aims to combine video games with medical expertise so that the same vision monitoring tools that are reliable and useful for doctors will be playful and fun for users. If Tilak can achieve that, the company tools will be “sticky” enough to have a longstanding impact on the healthcare process for patients. More
  • DNA Data Storage Alliance Makes Its Case in New White Paper, Website

    Jun 10 | Bio-IT World | The DNA Data Storage Alliance, an organization formed last year by Twist Bioscience Corporation, Illumina, and Western Digital together with Microsoft Research, has launched its website and released its first white paper, an introduction to DNA data storage, endorsed by 29 member organizations. More
  • Achieving AI: Pharma’s Digital Transformation Pathway

    Jun 10 | Bio-IT World | What does it mean for a pharmaceutical company to be digital and how do we get there? That’s what Reza Olfati-Saber, PhD, Global Head AI & Deep Analytics, Digital & Data Science R&D, at Sanofi tackled yesterday at the DECODE: AI for Pharmaceuticals forum. More
  • Biology’s Role As A Driver of the Future of Computation Development

    Jun 09 | Bio-IT World | At the DECODE: AI for Pharmaceuticals forum yesterday, Puneet Batra, director of machine learning at the Broad Institute, outlined the mission of the new Eric and Wendy Schmidt Center at the Broad: to position biology to drive the next era of computing. More
  • Biotechs, Pharma Talk Cloud at AWS Symposium

    Jun 08 | Bio-IT World | At the AWS Healthcare and Life Sciences symposium last week, several biotech, pharma, and genomics organizations presented their cloud-enabled workflows and highlighted how Amazon Web Services is enabling their research and efforts. More
  • Data Vision: How Pharma’s View of Data is Changing Healthcare

    Jun 08 | Bio-IT World | Kicking off the DECODE: AI for Pharmaceuticals forum held virtually this week, speakers from big pharma discussed the cultural challenges required to become a data-driven business and how doing so might position us for the next horizon in personalized medicine. More
  • New Fund for Early-Stage Life Sciences, Microscopy for Protein Dynamics: Follow the Money

    Jun 03 | Bio-IT World | AI for gene therapy, gastrointestinal disease, and other indications, VAST Data’s disaggregation of hardware and software, targeting transcription factors as druggable regions, a new approach to sharing computational research, and more. More
  • The FDA Doesn’t Show Signs of Slowing Down – How Can Pre-Revenue Life Sciences Companies Keep Up?

    Jun 02 | Bio-IT World | With the FDA working at a record pace, how can life sciences companies keep up and effectively move through the drug development life cycle? Answer: A robust technology solution that enables granular tracking of spending and scale as the as the company rapidly grows and moves through the four main stages of drug development: start-up, IPO, clinical trials, and commercialization. More
  • New Pandemic Sciences Centre, Alliances on Health, New Products

    Jun 01 | Bio-IT World | University of Oxford launches a new Pandemic Sciences Centre, Sema4 partners with AdventHealth, IQVIA reports on R&D trends, American Heart Association allies with Hitachi Vantara, Biogen and Ginkgo pursue a novel gene therapy manufacturing platform, and new products from TripleBlind, Twist Bioscience. More
  • Becoming Data-Driven Across International Borders: Key Translation Considerations

    May 28 | Bio-IT World | Big data is often used by businesses to analyze and expand into foreign markets, but there are added complexities when it comes to processing data that crosses international borders. Gathering data in multiple languages layers complexity onto any research. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight

Digital Therapeutics: Taking digital health to a new level
Benchling is the most widely-adopted life sciences R&D cloud. Accelerate, measure, and forecast R&D – from discovery through bioprocessing – all in one place. It’s a fully unified platform that centralizes and standardizes all R&D data, so you can spend less time fighting with legacy software, and more time reaching breakthrough discoveries.
Read more here!